Diagnosis and management of children with Blue Rubber Bleb Nevus Syndrome: A multi-center case series.


Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
11 2019
Historique:
received: 17 11 2018
revised: 10 03 2019
accepted: 01 04 2019
pubmed: 31 7 2019
medline: 5 6 2020
entrez: 31 7 2019
Statut: ppublish

Résumé

Blue Rubber Bleb Nevus Syndrome (BRBNS) is a rare, severe, sporadically occurring disorder characterized by multiple venous malformations. To present and analyze a case series of pediatric patients with BRBNS and to describe diagnostic approaches and management options applied. Multicenter, retrospective study, evaluating the diagnosis and management of children with BRBNS. Eighteen patients diagnosed with BRBNS were included. Cutaneous venous malformations were observed in 78% and gastrointestinal venous malformations in 89%. Lesions were also found in other organs including muscles, joints, central nervous system, eyes, parotid gland, spine, kidneys and lungs. Gastrointestinal lesions were more common in the small intestine than in stomach or colon. The management varied significantly among centers. Endoscopic therapy and surgical therapy alone failed to prevent recurrence of lesions. In younger children and in patients with musculoskeletal or other organ involvement, sirolimus was used with 100% success rate in our series (5 patients treated) although poor compliance with subtherapeutic sirolimus trough levels led to recurrence in a minority. Considering the multi-organ involvement in BRBNS, diagnosis and management requires a multidisciplinary approach. The treatment includes conservative, medical, endoscopic and surgical options. Prospective multicenter studies are needed to identify the optimal management of this rare condition.

Sections du résumé

BACKGROUND
Blue Rubber Bleb Nevus Syndrome (BRBNS) is a rare, severe, sporadically occurring disorder characterized by multiple venous malformations.
AIMS
To present and analyze a case series of pediatric patients with BRBNS and to describe diagnostic approaches and management options applied.
PATIENTS AND METHODS
Multicenter, retrospective study, evaluating the diagnosis and management of children with BRBNS.
RESULTS
Eighteen patients diagnosed with BRBNS were included. Cutaneous venous malformations were observed in 78% and gastrointestinal venous malformations in 89%. Lesions were also found in other organs including muscles, joints, central nervous system, eyes, parotid gland, spine, kidneys and lungs. Gastrointestinal lesions were more common in the small intestine than in stomach or colon. The management varied significantly among centers. Endoscopic therapy and surgical therapy alone failed to prevent recurrence of lesions. In younger children and in patients with musculoskeletal or other organ involvement, sirolimus was used with 100% success rate in our series (5 patients treated) although poor compliance with subtherapeutic sirolimus trough levels led to recurrence in a minority.
CONCLUSIONS
Considering the multi-organ involvement in BRBNS, diagnosis and management requires a multidisciplinary approach. The treatment includes conservative, medical, endoscopic and surgical options. Prospective multicenter studies are needed to identify the optimal management of this rare condition.

Identifiants

pubmed: 31358484
pii: S1590-8658(19)30679-6
doi: 10.1016/j.dld.2019.04.020
pii:
doi:

Substances chimiques

Sirolimus W36ZG6FT64

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1537-1546

Informations de copyright

Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Auteurs

Sara Isoldi (S)

Centre of Paediatric Gastroenterology, Sheffield Children's Hospital, Sheffield, United Kingdom. Electronic address: sara.isoldi@uniroma1.it.

Dalia Belsha (D)

Centre of Paediatric Gastroenterology, Sheffield Children's Hospital, Sheffield, United Kingdom.

Intan Yeop (I)

Great Ormond Street Hospital, London, United Kingdom.

Aliye Uc (A)

University of Iowa Carver College of Medicine, Iowa City, IA, United States.

Noam Zevit (N)

Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel Petach Tikva, Israel.

Petar Mamula (P)

Division of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.

Anthony Meneloas Loizides (AM)

Department of Pediatrics, Albert Einstein College of Medicine, Division of Pediatric Gastroenterology and Nutrition, Children's Hospital at Montefiore, Bronx, NY, United States.

Merit Tabbers (M)

Departments of Pediatric Gastroenterology, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.

Don Cameron (D)

Monash University and Southern Health, Parkville, Victoria, Australia.

Andrew S Day (AS)

Department of Paediatrics, University of Otago (Christchurch), Christchurch, NZ, United States.

Marwa Abu-El-Haija (M)

University of Iowa Carver College of Medicine, Iowa City, IA, United States.

Voranush Chongsrisawat (V)

Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Graham Briars (G)

Department of Paediatric Gastroenterology, Norfolk and Norwich University Hospital, Norwich, United Kingdom.

Keith J Lindley (KJ)

Great Ormond Street Hospital, London, United Kingdom.

Jutta Koeglmeier (J)

Great Ormond Street Hospital, London, United Kingdom.

Neil Shah (N)

Great Ormond Street Hospital, London, United Kingdom.

John Harper (J)

Institute of Child Health, University College London, United Kingdom.

Samira Batul Syed (SB)

Great Ormond Street Hospital, London, United Kingdom.

Mike Thomson (M)

Centre of Paediatric Gastroenterology, Sheffield Children's Hospital, Sheffield, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH